Technology Transfer News
Novel X-ray lens with potential commercial applications
PSI scientists have developed a ground-breaking achromatic lens for X-rays which facilitates the glimpse into the nanoworld. This allows the X-ray beams to be accurately focused on a single point even if they have different wavelengths. Soon, the newly developed lens will also be used in industry.
PSI Founder Fellowship goes into the next round!
What started as an idea a few years ago has been established itself at PSI as a valuable funding instrument for talented researchers or engineers: the PSI Founder Fellowship (PSIFF for short). It is aimed at researchers with an entrepreneurial spirit and is supported by UBS.
This year, two fellows from PSI are starting the program: Dr Sebastian Gliga from the "Photon Science Division" and Dr Lars Gerchow from the research division "Neutrons and Muons" convinced the PSIFF jury with their business ideas. We warmly congratulate the two budding young entrepreneurs and look forward to working with them!
PSI at the this year’s KMU Swiss Symposium!
This year's KMU Swiss Symposium will take place in Baden, Kt. Aargau, on 17 March - we are pleased to be physically present again this year!
The KMU Swiss Symposium offers a platform for exchange and inspiration - this is made possible by exciting presentations, various booths with innovative projects and networking.
Federal Councillor Viola Amherd will also be a guest in Baden on 17 March and will give the opening speech, followed by other top-class speakers, including Nina Suma, Managing Director of the Baden thermal spa "Fortyseven", neuroscientist Claudia Thali, Thomas Boyer, CEO of Groupe Mutuel and Guido Konrad, Managing Director of Varian Medical Imaging Labs.
PSI will be there - visit us at our joint booth with the Hightech Zentrum Aargau and find out more about how we can support industry and SMEs with their technical challenges and innovation processes.
Detailed information and registration for the event at:
https://www.kmuswiss.ch/index.cfm?setcatlist=1&publication_id=584&publication_action=dsp_publicationdetail&content=1050¶graph=1&spr=de
Covid-19: New, better coronavirus rapid test
Researchers at the Paul Scherrer Institute PSI and the University of Basel have developed a rapid test for Covid-19. Its novel functional principle promises reliable and quantifiable results concerning a patient's Covid-19 disease and its course – as well as evidence concerning other diseases and Covid variants that may be present.
Now a new test developed at PSI – which, unlike antigen tests, does not directly detect components of the virus, but rather the antibodies the immune system produces in response to the infection –promises to bring substantially more predictive power to rapid testing. It is just as inexpensive, quick, and easy to use, and it can also be used to simultaneously identify a variety of pathogens, such as those responsible for the flu.
Before it can go into widespread use, however, it still must undergo further testing and optimisation.
Research for semiconductor electronics
PSI researchers, together with researchers from Cornell University in New York State, have identified a composite material that could integrate quantum devices into semiconductor technology, making electronic components significantly more powerful. Among the most important challenges currently facing semiconductor electronics are improvements that would increase data transmission bandwidth, energy efficiency and information security. The incorporation of quantum effects could provide a new breakthrough and could be trend-setting for the semiconductur-industry.
Effective combination cancer treatment
Researchers at the Paul Scherrer Institute PSI have tested various methods to check how effective they are in combatting certain types of cancer. They found a combination of two preparations to be much more effective than treatment with just one of the two active substances. This is particularly important for the treatment of modular thyroid carcinomas. If the results obtained so far are confirmed in future studies, this therapy could be available to the general public in a few years.
Info- & Networkingveranstaltung: "Technologien für die Industrie nutzbar machen"
ANAXAM und Swiss m4m Center – Die beiden Advanced Manufacturing Technology Transfer Center blicken auf ein erfolgreiches erstes Jahr zurück und geben einen Einblick in ihre Aktivitäten.
Wann: Freitag, 03. Dezember 2021, ab 16:00 Uhr
Wo: kultur & kongresshaus aarau
Registrieren Sie sich für den Anlass und erfahren Sie, wie Sie die Kompetenzen und Technologien von ANAXAM und Swiss m4m Center für Ihr Unternehmen einsetzen und dadurch die Innovationskraft steigern können!
Programm und Online-Anmeldung: https://hightechzentrum.ch/event/info-und-networkinganlass-der-advanced-manufacturing-centers-anaxam-und-swissm4m
PSI and ANAXAM at the this year's Swiss Innovation Forum!
A fundamental basis for success in these special times is innovation, which is largely driven by exchange and inspiration. The Swiss Innovation Forum (SIF) 2021 brings both together in one place. That is why we are supporting this year's edition of the SIF as a partner.
Meet innovative minds from different industries at the Congress Center Basel on 18th November 2021 , exchange ideas and create new visions. Future-oriented experts will furthermore take you on a journey full of ideas. It will be rounded off by the FutureExpo, which invites you to discover and try things out, and the 33rd Swiss Technology Award ceremony, at which the best tech innovations of the year are honoured.
PSI will be there - visit us at our booth and find out more about how the technology transfer centre ANAXAM uses state-of-the-art material analysis to support both industry and SMEs in optimising production methods and processes, thus creating the basis for innovations.
Detailed information and registration for the conference at www.swiss-innovation.com/en/
Protein Distancing
Using a protein fusion approach that uses a modular linker PSI Researchers can now connect two unrelated proteins at a defined distance and orientation to each other. This technology could allow for applications e.g. in vaccine development or could facilitate the crystallization of proteins for drug development. Furthermore, the linker holds potential as a component in protein-based nanomaterials. Feel free to contact us if you are interested in learning more about this exiting technology.
https://www.psi.ch/en/media/our-research/protein-distancing